Table 1.

Characteristics of SAH patients with and without DCI

	Columbia			Houston			Aachen
	Total Patients 310		-	Total Patients 38		-	Total Patients 40		-

	DCI+	DCI−	p value	DCI+	DCI−	p value	DCI+	DCI−	p value
	n=101	n=209	p value	n=12	n=26	p value	n=11	n=29	p value

Age, y, median (IQR)	54 (45-65)			57 (46-65)		0.765	59 (49-65.5)		0.137
Age, y, median (IQR)
50 (44-62)	56 (47-66)	0.033^*	53 (49-60)	59 (45-70)	0.285	52 (48-60)	60 (53-66)	0.055

Female Gender, n (%)	218 (70.3)			28 (73.7)		0.85	27 (67.5)		0.716
Female Gender, n (%)
81 (80.2)	137 (65.6)	0.008^*	12 (100.0)	16 (61.5)	0.016^*	9 (81.8)	18 (62.1)	0.286

Hispanic Ethnicity, n (%)	99 (31.9)			12 (31.6)		1	0 (0.0)		N/A
Hispanic Ethnicity, n (%)
30 (29.7)	69 (33.0)	0.604	3 (25.0)	9 (34.6)	0.714	0 (0.0)	0 (0.0)	1

Tobacco Use, n (%)	166 (53.6)			20 (52.6)		1	15 (37.5)		0.065
Tobacco Use, n (%)
55 (54.5)	111 (53.1)	0.713	9 (75.0)	11 (42.3)	0.086	5 (45.5)	10 (34.5)	0.716

Hypertension History	146 (47.1)			27 (71.0)		0.006^*	16 (40.0)		0.5
Hypertension History
39 (38.6)	107 (51.2)	0.04^*	11 (91.7)	16 (61.5)	0.121	7 (63.6)	9 (31.0)	0.08

HH, 4 - 5, n (%)	88 (28.4)			19 (50.0)		0.008^*	15 (37.5)		0.269
HH, 4 - 5, n (%)
40 (39.6)	48 (23.0)	0.003^*	5 (41.7)	14 (53.8)	0.728	7 (63.6)	8 (27.6)	0.065

WFNS, 4 - 5, n (%)	121 (39.0)			22 (57.9)		0.035^*	17 (42.5)		0.732
WFNS, 4 - 5, n (%)
50 (49.5)	71 (34.0)	0.009^*	7 (58.3)	15 (57.7)	1	7 (63.6)	10 (34.5)	0.153

GCS, median (IQR)	14 (8-15)			8 (5-14)		<0.001^*	13 (7-15)		0.101
GCS, median (IQR)
13 (6-15)	15 (9-15)	<0.001^*	9 (6-13)	8 (5-14)	0.95	7 (6-13)	13 (8-15)	0.053

mFS, 3 - 4, n (%)	120 (38.7)			38 (100.0)		<0.001^*	20 (50.0)		0.175
mFS, 3 - 4, n (%)
38 (37.6)	82 (39.2)	0.805	12 (100.0)	26 (100.0)	1	9 (81.8)	11 (37.9)	0.031^*

mFS 0, n (%)	0 (0.0)	15 (7.2)		0 (0.0)	0 (0.0)		0 (0.0)	0 (0.0)
mFS 1, n (%)	15 (14.9)	41 (19.6)		0 (0.0)	0 (0.0)		2 (18.2)	12 (41.4)
mFS 2, n (%)	48 (47.5)	71 (34.0)		0 (0.0)	0 (0.0)		0 (0.0)	6 (20.7)
mFS 3, n (%)	32 (31.7)	73 (34.9)		6 (50.0)	19 (73.1)		4 (36.4)	3 (10.34)
mFS 4, n (%)	6 (5.9)	9 (4.3)		6 (50.0)	7 (26.9)		5 (45.5)	8 (27.6)

Vasopressor Use, n (%)	66/242 (27.3)			20 (52.6)		0.002^*	37 (92.5)		<0.001^*
Vasopressor Use, n (%)
47/78 (60.3)	19/164 (11.6)	<0.001^*	10 (83.3)	10 (38.5)	0.015^*	11 (100)	26 (89.7)	0.548

Cerebral Edema, n (%)	176 (56.77)			10 (26.32)		<0.001	8 (20)		<0.0001
Cerebral Edema, n (%)
76 (75.2)	100 (47.8)	<0.0001^*	4 (33.3)	6 (23.1)	0.694	4 (36.4)	4 (13.8)	0.182

Fever >38.6°C, n (%)	126 (40.65)			26 (68.42)		0.002*	34 (85)		<0.0001*
Fever >38.6°C, n (%)
54 (53.5)	72 (34.4)	0.002^*	8 (66.7)	18 (69.2)	1	11 (100)	23 (79.3)	0.162

Hydrocephalus, n (%)	143 (46.1)			26 (68.4)		0.010^*	34 (85.0)		<0.0001^*
Hydrocephalus, n (%)
61 (60.4)	82 (39.2)	<0.001^*	9 (75.0)	17 (65.4)	0.714	11 (100)	23 (79.3)	0.162

Pulmonary Edema, n (%)	51 (16.5)			9 (23.7)		0.260	10 (25.0)		0.186
Pulmonary Edema, n (%)
27 (26.7)	24 (11.5)	0.001^*	4 (33.3)	5 (19.2)	0.423	3 (27.3)	7 (24.1)	1

Seizures, n (%)	32 (10.3)			3 (7.9)		0.782	11 (27.5)		0.004^*
Seizures, n (%)
12 (11.9)	20 (9.6)	0.553	1 (8.3)	2 (7.6)	1	3 (27.3)	8 (27.6)	1

In-Hospital Mortality, n (%)	34 (11.0)			3 (7.9)		0.781	9 (22.5)		0.068
In-Hospital Mortality, n (%)
8 (7.9)	26 (12.4)	0.253	0 (0.0)	3 (11.54)	0.538	5 (45.5)	4 (13.8)	0.083

LOS, d, median (IQR)	14.9 (11-22)			13 (10-17)		0.103	14.5 (11-20)		0.474
LOS, d, median (IQR)
22 (17-30)	12 (10-16)	<0.0001^*	18 (16-21)	12 (9-14)	0.004^*	18 (15-25)	14 (9-18)	0.022^*

mRS at Discharge, 3 - 6, n (%)	195 (62.9)			35 (92.1)		<0.001^*	24 (60.0)		0.730
mRS at Discharge, 3 - 6, n (%)
89 (88.1)	106 (50.7)	<0.0001^*	10 (83.3)	25 (96.2)	0.229	9 (81.8)	15 (51.7)	0.148

mRS at 3 Months, 3 - 6, n (%)	92/238 (38.7)			16/29 (55.2)		0.108	15/27 (55.6)		0.101
mRS at 3 Months, 3 - 6, n (%)
40/74 (54.1)	52/164 (31.7)	0.001^*	4/11 (36.4)	12/18 (66.7)	0.143	6/9 (22.2)	9/18 (50.0)	0.683

mRS at 12 Months, 3 - 6, n (%)	93/229 (40.6)			8/14 (57.1)		0.268	11/19 (57.9)		0.154
mRS at 12 Months, 3 - 6, n (%)
36/70 (51.4)	57/159 (35.8)	0.029^*	2/4 (50.0)	6/10 (60.0)	1	6/7 (85.7)	5/12 (41.7)	0.147

statistically significant